Early research (Phase 1)Study completedNCT04442347
What this trial is testing
Phase 1b Study to Assess Safety, Tolerability, and Pharmacokinetics of ARCT-810 in Stable Adult Subjects With Ornithine Transcarbamylase Deficiency
Who this might be right for
Ornithine Transcarbamylase Deficiency
Arcturus Therapeutics, Inc. 16